Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory Clinical Study of TILs Treatment for Metastatic or Recurrent Cervical Cancer

NCT04674488 is registered in ClinicalTrials.gov with Shanghai OriginCell Therapeutics Co., Ltd. as lead sponsor.

NCT NCT04674488
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04674488 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory Clinical Study of TILs Treatment for Metastatic or Recurrent Cervical Cancer
Lead sponsor
Shanghai OriginCell Therapeutics Co., Ltd.
Phase
Phase 1
Overall status
Unknown status
Start date
December 9, 2020
Completion date
November 9, 2024
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tils, metastatic or recurrent cervical cancer